For all treated chlamydia infections, 14.0% of patients received doxycycline—the CDC's recommended treatment—alone or with ...

The U.S. Food and Drug Administration (FDA) has granted Visby Medical marketing authorization for its Women’s Sexual Health ...

The FDA on Friday granted marketing authorization to the first at-home test for diagnosing chlamydia, gonorrhea, and ...

The US Food and Drug Administration (FDA) has granted marketing authorization for the first at-home test to diagnose ...

Prompt treatment of chlamydia and gonorrhea following a confirmed diagnosis is essential to prevent complications and reduce ...

UK health officials say 17 cases of ceftriaxone-resistant gonorrhea were reported from January 2024 to March 20, 2025, ...

This study aimed to quantify the overall treatment rate for chlamydia and gonorrhea and identify factors associated with treatment delays and disparities.

The at-home kit, according to the FDA, is the first of its kind to test for chlamydia, gonorrhea and trichomoniasis ... resulting in delayed diagnosis or treatment,” Courtney Lias, director ...

The FDA reviewed this test under the FDA’s De Novo premarket review pathway, a regulatory pathway for low- to moderate-risk ...

In November 2023, the Joint Committee on Vaccination and Immunisation (JCVI) recommended a targeted roll-out of the MenB ...